These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3592635)

  • 1. Mode of estrogen action on cell proliferation in CAMA-1 cells: III. Effect of antiestrogen.
    Leung BS
    Anticancer Res; 1987; 7(2):219-25. PubMed ID: 3592635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of estrogen action on cell proliferation in CAMA-1 cells: II. Sensitivity of G1 phase population.
    Leung BS; Potter AH
    J Cell Biochem; 1987 Jul; 34(3):213-25. PubMed ID: 3611201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M; Bolan G; Huff K
    Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR; Sutherland RL
    Cancer Res; 1987 Oct; 47(20):5323-9. PubMed ID: 3652038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells.
    Sutherland RL; Hall RE; Taylor IW
    Cancer Res; 1983 Sep; 43(9):3998-4006. PubMed ID: 6871841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
    Lykkesfeldt AE; Larsen JK; Christensen IJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S83-90. PubMed ID: 3742066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR; Murphy LC; Hall RE; Sutherland RL
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR; Murphy LC; Sutherland RL
    Cancer Res; 1984 Jun; 44(6):2398-405. PubMed ID: 6722780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-sensitive proliferation pattern of cloned Syrian hamster kidney tumor cells.
    Soto AM; Bass JC; Sonnenschein C
    Cancer Res; 1988 Jul; 48(13):3676-80. PubMed ID: 3288332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
    Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
    Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
    Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of tumor-associated fatty acid synthase activity antagonizes estradiol- and tamoxifen-induced agonist transactivation of estrogen receptor (ER) in human endometrial adenocarcinoma cells.
    Menendez JA; Oza BP; Atlas E; Verma VA; Mehmi I; Lupu R
    Oncogene; 2004 Jun; 23(28):4945-58. PubMed ID: 15094777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of tamoxifen and estradiol on the growth of human breast cancer cells in vitro.
    Arafah BM; Griffin P; Gordon NH; Pearson OH
    Cancer Res; 1986 Jul; 46(7):3268-72. PubMed ID: 3708561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estradiol on proliferation and on cell loss in the MXT mouse mammary tumor.
    Kiss R; Danguy A; Heuson JC; Paridaens R
    Anticancer Res; 1986; 6(6):1321-8. PubMed ID: 3813488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.